Articles by Philip Scheltens (10)

Can we do better in developing new drugs for Alzheimer's disease?

Serge Gauthier and Philip Scheltens

Alzheimer`s & Dementia 5 ( 6 ): 489 - 491 , 2009

The diagnosis of dementia due to Alzheimer‘s disease: Recommendations from the National Institute on Aging-Alzheimer‘s Association workgroups on diagnostic guidelines for Alzheimer's disease

Guy M. McKhann, David S. Knopman, Howard Chertkow, Howard Chertkow, Clifford R. Jack, Claudia H. Kawas, William E. Klunk, Walter J. Koroshetz, Jennifer J. Manly, Richard Mayeux, Richard C. Mohs, John C. Morris, Martin N. Rossor, Philip Scheltens, Maria C. Carrillo, Bill Thies, Sandra Weintraub and Creighton H. Phelps

Alzheimer`s & Dementia 7 ( 3 ): 263 - 269 , 2011

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer‘s Association Research Roundtable Workgroup

Reisa A. Sperling, Clifford R. Jack, Sandra E. Black, Matthew P. Frosch, Steven M. Greenberg, Bradley T. Hyman, Philip Scheltens, Maria C. Carrillo, William Thies, Martin M. Bednar, Ronald S. Black, H. Robert Brashear, Michael Grundman, Eric R. Siemers, Howard H. Feldman and Rachel J. Schindler

Alzheimer`s & Dementia 7 ( 4 ): 367 - 385 , 2011

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer‘s disease

Clifford R. Jack, Frederik Barkhof, Matt A. Bernstein, Marc Cantillon, Patricia E. Cole, Charles DeCarli, Bruno Dubois, Simon Duchesne, Nick C. Fox, Giovanni B. Frisoni, Harald Hampel, Derek L.G. Hill, Keith Johnson, Jean-Francois Mangin, Philip Scheltens, Adam J. Schwarz, Reisa Sperling, Joyce Suhy, Paul M. Thompson, Michael Weiner and Norman L. Foster

Alzheimer`s & Dementia 7 ( 4 ): 474 - 485 , 2011

How golden is the gold standard of neuropathology in dementia?

Philip Scheltens and Kenneth Rockwood

Alzheimer`s & Dementia 7 ( 4 ): 486 - 489 , 2011

A new informant-based questionnaire for instrumental activities of daily living in dementia

Sietske A.M. Sikkes, Elly S.M. de Lange-de Klerk, Yolande A.L. Pijnenburg, Freek Gillissen, Rolinka Romkes, Dirk L. Knol, Bernard M.J. Uitdehaag and Philip Scheltens

Alzheimer`s & Dementia 8 ( 6 ): 536 - 543 , 2012

Comparison of International Working Group criteria and National Institute on Aging�Alzheimer‘s Association criteria for Alzheimer‘s disease

Pieter Jelle Visser, Stephanie Vos, Ineke van Rossum and Philip Scheltens

Alzheimer`s & Dementia 8 ( 6 ): 560 - 563 , 2012

A prediction model to calculate probability of Alzheimer‘s disease using cerebrospinal fluid biomarkers

Petra E. Spies, Jurgen A.H.R. Claassen, Petronella G.M. Peer, Marinus A. Blankenstein, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Marcel G.M. Olde Rikkert and Marcel M. Verbeek

Alzheimer`s & Dementia 9 ( 3 ): 262 - 268 , 2013

Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia

Esther L.G.E. Koedam, Annelies E. van der Vlies, Wiesje M. van der Flier, Nicolaas A. Verwey, Ted Koene, Philip Scheltens, Marinus A. Blankenstein and Yolande A.L. Pijnenburg

Alzheimer`s & Dementia 9 ( 3 ): 269 - 275 , 2013

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer‘s disease study

Wesley Jongbloed, Maartje I. Kester, Wiesje M. van der Flier, Robert Veerhuis, Philip Scheltens, Marinus A. Blankenstein and Charlotte E. Teunissen

Alzheimer`s & Dementia 9 ( 3 ): 276 - 283 , 2013